-
3
-
-
0029796606
-
-
(c) A. Holy, H. Dvorakova, J. Jindrich, M. Masojidkova, M. Budesinsky, J. Balzarini, G. Andrei and E. De Clercq, J. Med. Chem., 1996, 39, 4073-4088
-
(1996)
J. Med. Chem.
, vol.39
, pp. 4073-4088
-
-
Holy, A.1
Dvorakova, H.2
Jindrich, J.3
Masojidkova, M.4
Budesinsky, M.5
Balzarini, J.6
Andrei, G.7
De Clercq, E.8
-
4
-
-
0345004991
-
-
(d) A. Holy, J. Günter, H. Dvorakova, M. Masojidkova, G. Andrei, R. Snoeck, J. Balzarini and E. De Clercq, J. Med. Chem., 1999, 42, 2064-2086 (and references cited therein)
-
(1999)
J. Med. Chem.
, vol.42
, pp. 2064-2086
-
-
Holy, A.1
Günter, J.2
Dvorakova, H.3
Masojidkova, M.4
Andrei, G.5
Snoeck, R.6
Balzarini, J.7
De Clercq, E.8
-
6
-
-
0022450584
-
-
(a) E. De Clercq, A. Holy, I. Rosenberg, T. Sakuma, J. Balzarini and P. C. Maudgal, Nature, 1986, 323, 464-467
-
(1986)
Nature
, vol.323
, pp. 464-467
-
-
De Clercq, E.1
Holy, A.2
Rosenberg, I.3
Sakuma, T.4
Balzarini, J.5
Maudgal, P.C.6
-
7
-
-
0023607245
-
-
(b) E. De Clercq, T. Sakuma, M. Baba, R. Pauwels, J. Balzarini, I. Rosenberg and A. Holy, Antiviral Res., 1987, 8, 261-272
-
(1987)
Antiviral Res.
, vol.8
, pp. 261-272
-
-
De Clercq, E.1
Sakuma, T.2
Baba, M.3
Pauwels, R.4
Balzarini, J.5
Rosenberg, I.6
Holy, A.7
-
9
-
-
0025240879
-
-
J. Balzarini, H. Sobis, L. Naesens, M. Vandeputte and E. De Clercq, Int. J. Cancer, 1990, 45, 486-489.
-
(1990)
Int. J. Cancer
, vol.45
, pp. 486-489
-
-
Balzarini, J.1
Sobis, H.2
Naesens, L.3
Vandeputte, M.4
De Clercq, E.5
-
10
-
-
0024443304
-
-
J. D. Gangemi, R. M. Cozens, E. De Clercq, J. Balzarini and H. K. Hochkeppel, Antimicrob. Agents Chemother., 1989, 33, 1864-1868.
-
(1989)
Antimicrob. Agents Chemother.
, vol.33
, pp. 1864-1868
-
-
Gangemi, J.D.1
Cozens, R.M.2
De Clercq, E.3
Balzarini, J.4
Hochkeppel, H.K.5
-
11
-
-
0027253824
-
-
R. A. Heijtink, G. A. Dewilde, J. Kruining, L. Berk, J. Balzarini, E. De Clercq, A. Holy and S. W. Schalm, Antiviral Res., 1993, 21, 141-153.
-
(1993)
Antiviral Res.
, vol.21
, pp. 141-153
-
-
Heijtink, R.A.1
Dewilde, G.A.2
Kruining, J.3
Berk, L.4
Balzarini, J.5
De Clercq, E.6
Holy, A.7
Schalm, S.W.8
-
12
-
-
0028792567
-
-
K. C. Cundy, P. A. Barditch-Crovo, R. E. Walker, A. C. Collier, D. Ebeling, J. Toole and H. S. Jaffe, Antimicrob. Agents Chemother., 1995, 39, 2401-2405.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 2401-2405
-
-
Cundy, K.C.1
Barditch-Crovo, P.A.2
Walker, R.E.3
Collier, A.C.4
Ebeling, D.5
Toole, J.6
Jaffe, H.S.7
-
13
-
-
0034741936
-
-
D. Rejman, M. Masojidkova, E. De Clercq and I. Rosenberg, Nucleosides Nucleotides, 2001, 20, 1497-1522 (and references cited therein).
-
(2001)
Nucleosides Nucleotides
, vol.20
, pp. 1497-1522
-
-
Rejman, D.1
Masojidkova, M.2
De Clercq, E.3
Rosenberg, I.4
-
14
-
-
33748732186
-
-
W. Chen, M. T. Flavin, R. Filler and Z.-Q. Xu, J. Chem. Soc., Perkin Trans. 1, 1998, 3979-3988.
-
(1998)
J. Chem. Soc., Perkin Trans. 1
, pp. 3979-3988
-
-
Chen, W.1
Flavin, M.T.2
Filler, R.3
Xu, Z.-Q.4
-
15
-
-
11344272219
-
-
K. Hartmann, M. Kuffer, J. Balzarini, L. Naesens, M. Goldberg, V. Erfle, F. D. Goebel, E. De Clercq, J. Jindrich, A. Holy, N. Bischofberger and W. Kraft, J. Acquired Immune Defic. Syndr. Hum. Retrovirol., 1998, 17, 120-128.
-
(1998)
J. Acquired Immune Defic. Syndr. Hum. Retrovirol.
, vol.17
, pp. 120-128
-
-
Hartmann, K.1
Kuffer, M.2
Balzarini, J.3
Naesens, L.4
Goldberg, M.5
Erfle, V.6
Goebel, F.D.7
De Clercq, E.8
Jindrich, J.9
Holy, A.10
Bischofberger, N.11
Kraft, W.12
-
19
-
-
0031966184
-
-
(d) V. K. Brel, Synthesis, 1998, 1998, 710-712
-
(1998)
Synthesis
, pp. 710-712
-
-
Brel, V.K.1
-
21
-
-
0346242557
-
-
Abstract 132, New Orleans, Division of Organic Chemistry
-
(f) V. K. Brel and P. J. Stang, 225th ACS National Meeting, 2003, Abstract 132, New Orleans, Division of Organic Chemistry.
-
225th ACS National Meeting, 2003
-
-
Brel, V.K.1
Stang, P.J.2
-
22
-
-
0002208958
-
-
ed. C. K. Chu and D. C. Baker, Plenum Press, New York
-
(a) J. Zemlicka, in Nucleosides and Nucleotides as Antitumour and Antiviral Agents, ed. C. K. Chu and D. C. Baker, Plenum Press, New York, 1993, 73-100
-
(1993)
Nucleosides and Nucleotides as Antitumour and Antiviral Agents
, pp. 73-100
-
-
Zemlicka, J.1
-
23
-
-
0026534343
-
-
(b) S. Megati, S. Phadtare and J. Zemlicka, J. Org. Chem., 1992, 57, 2320-2327.
-
(1992)
J. Org. Chem.
, vol.57
, pp. 2320-2327
-
-
Megati, S.1
Phadtare, S.2
Zemlicka, J.3
-
24
-
-
0001154963
-
-
(Russ. Chem. Rev. (Engl. Trans.), 1997, 66, 205-224)
-
I. V. Alabugin and V. K. Brel, Usp. Khim., 1997, 66, 225-245 (Russ. Chem. Rev. (Engl. Trans.), 1997, 66, 205-224)
-
(1997)
Usp. Khim.
, vol.66
, pp. 225-245
-
-
Alabugin, I.V.1
Brel, V.K.2
-
25
-
-
4244213959
-
-
(Chem. Abs., 1998, 128, 114977r).
-
(1998)
Chem. Abs.
, vol.128
-
-
-
27
-
-
0003623760
-
-
ed. S. R. Landor, Academic, London
-
R. Wolfgang, in The Chemistry of Allenes, ed. S. R. Landor, Academic, London, 1982, vol. 2.
-
(1982)
The Chemistry of Allenes
, vol.2
-
-
Wolfgang, R.1
-
28
-
-
0346872852
-
-
X-Ray studies were executed in the L. Karpov of Institute of Physics-Chemistry, Moscow
-
X-Ray studies were executed in the L. Karpov of Institute of Physics-Chemistry, Moscow.
-
-
-
-
29
-
-
0346872870
-
-
A. N. Chekhlov, V. K. Brel, E. V. Abramkin and N. S. Zefirov, Dokl. Akad. Nauk SSSR, 1991, 319, 417-421.
-
(1991)
Dokl. Akad. Nauk SSSR
, vol.319
, pp. 417-421
-
-
Chekhlov, A.N.1
Brel, V.K.2
Abramkin, E.V.3
Zefirov, N.S.4
-
30
-
-
0347503400
-
-
A. M. Gazaliev, O. A. Nurkenov, R. Z. Kasenov, K. M. Turdybekov and Yu. T. Struchkov, Zh. Obshch. Khim., 1992, 62, 1522-1528.
-
(1992)
Zh. Obshch. Khim.
, vol.62
, pp. 1522-1528
-
-
Gazaliev, A.M.1
Nurkenov, O.A.2
Kasenov, R.Z.3
Turdybekov, K.M.4
Struchkov, Yu.T.5
-
33
-
-
0009500129
-
-
S. M. Tret'yak, V. V. Mitkevich and L. F. Sukhodub, Kristallografiya, 1987, 32, 1268-1280.
-
(1987)
Kristallografiya
, vol.32
, pp. 1268-1280
-
-
Tret'yak, S.M.1
Mitkevich, V.V.2
Sukhodub, L.F.3
-
34
-
-
11344284526
-
-
F. H. Allen, O. Kennard and D. G. Watson, J. Chem. Soc., Perkin Trans. 2, 1987, N12, S1.
-
(1987)
J. Chem. Soc., Perkin Trans. 2
, vol.N12
-
-
Allen, F.H.1
Kennard, O.2
Watson, D.G.3
|